
Aptar’s Unidose Nasal Powder System Featured in Phase II Study of ENA’s INNA-051 Nasal Spray
Aptar’s Introduction to INNA-051 Investigational Nasal Spray AptarGroup a global leader in drug delivery, dosing, and protection technologies, has announced the use of its Unidose (UDS) Powder Nasal Spray System in a Phase II clinical study being conducted by ENA…












